Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Goodwill (2020 - 2025)

Marimed (MRMD) has disclosed Goodwill for 5 consecutive years, with $15.8 million as the latest value for Q3 2024.

  • On a quarterly basis, Goodwill rose 31.84% to $15.8 million in Q3 2024 year-over-year; TTM through Sep 2024 was $15.8 million, a 31.84% increase, with the full-year FY2023 number at $12.0 million, up 48.45% from a year prior.
  • Goodwill was $15.8 million for Q3 2024 at Marimed, roughly flat from $15.8 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $15.8 million in Q1 2024 to a low of $2.1 million in Q4 2020.
  • A 5-year average of $8.7 million and a median of $8.1 million in 2022 define the central range for Goodwill.
  • Peak YoY movement for Goodwill: changed 0.0% in 2021, then skyrocketed 480.46% in 2023.
  • Marimed's Goodwill stood at $2.1 million in 2020, then changed by 0.0% to $2.1 million in 2021, then skyrocketed by 290.67% to $8.1 million in 2022, then surged by 48.45% to $12.0 million in 2023, then soared by 31.84% to $15.8 million in 2024.
  • Per Business Quant, the three most recent readings for MRMD's Goodwill are $15.8 million (Q3 2024), $15.8 million (Q2 2024), and $15.8 million (Q1 2024).